UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040096
Receipt number R000045592
Scientific Title Quantitative assessment of periocular changes in the eyes treated by glaucoma drops
Date of disclosure of the study information 2020/04/10
Last modified on 2020/04/07 17:20:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Quantitative assessment of periocular changes in the eyes treated by glaucoma drops

Acronym

Quantitative assessment of periocular changes in the eyes treated by glaucoma drops

Scientific Title

Quantitative assessment of periocular changes in the eyes treated by glaucoma drops

Scientific Title:Acronym

Quantitative assessment of periocular changes in the eyes treated by glaucoma drops

Region

Japan


Condition

Condition

glaucoma

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess quantitatively the changes in the eye treated by glaucoma drops

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The change in the interpupillary distance 3 months after continual instillation of glaucoma drops in glaucoma patients

Key secondary outcomes

The change in the interpupillary distance 1 and 6 months after continual instillation of glaucoma drops in glaucoma patients
Visual acuity, Intra ocular pressure, exophthalmos


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Glaucoma patients who need treatment with eye drops

Key exclusion criteria

the use of topical or systemic
steroid or nonsteroidal anti-inflammatory drugs;
intraocular, ocular surface, eyelid, or periocular surgeries
during the observation period; and a history of disorders
that might have affected the ocular position including strabismus, abnormal thyroid function, and central nervous
system dysfunction.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Takayuki
Middle name
Last name Kamiya

Organization

Asahikawa Medical University

Division name

Ophthalmology

Zip code

078-8510

Address

Midorigaoka hibachi 2-1-1-1, Asahikawa 078-8510, Japan

TEL

0166-65-2111

Email

t-kamiya@asahikawa-med.ac.jp


Public contact

Name of contact person

1st name Takayuki
Middle name
Last name Kamiya

Organization

Asahikawa Medical University

Division name

Ophthalmology

Zip code

078-8510

Address

Midorigaoka hibachi 2-1-1-1, Asahikawa 078-8510, Japan

TEL

0166-65-2111

Homepage URL


Email

t-kamiya@asahikawa-med.ac.jp


Sponsor or person

Institute

Asahikawa Medical University

Institute

Department

Personal name



Funding Source

Organization

Japan Society For The Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Jichi Medical University
Asahikawa Eye Clinic
Engaru Yamaguchi Eye Clinic
Konnno Suguru Eye Clinic
Wakkanai City Hospital
Nemuro City Hospital
Nayoro City General Hospital
Yakumo General Hospital
Engaru-Kosei General Hospital
Shibetsu City Hospital
Kouiki Monbetsu Hospital
Bihoro Chouritsu Kokuminkenkouhoken Hospital
Okubo Eye Clinic
JCHO Tokyo Shinjuku Medical Center
Takahashi Eye Clinic
Hara Eye Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Asahikawa Medical Univesity Research Ethics Committee

Address

Midorigaoka hibachi 2-1-1-1, Asahikawa 078-8510, Japan

Tel

0166-68-2297

Email

rs-kk.g@asahikawa-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 10 Month 25 Day

Date of IRB

2020 Year 02 Month 25 Day

Anticipated trial start date

2020 Year 02 Month 25 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2020 Year 04 Month 07 Day

Last modified on

2020 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045592


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name